Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 09-Apr-24 6:38 PM View:  | Gustafson Kurt A Executive VP, Finance and CFO | Omniab, Inc. (OABI) | 08-Apr-24 | Option Sale | 6,954 | $5.27 | $36,647.60 | (4%) 183.65K to 176.7K | |
| 09-Apr-24 6:37 PM View: | Berkman Charles S Chief Legal Officer | Omniab, Inc. (OABI) | 08-Apr-24 | Option Sale | 6,954 | $5.27 | $36,647.60 | (2%) 299.57K to 292.62K | |
| 09-Apr-24 6:38 PM View: | Foehr Matthew W President and CEO Director | Omniab, Inc. (OABI) | 07-Apr-24 | Payment of Exercise | 18,477 | $5.31 | $98,112.90 | (< 1%) 3.19M to 3.17M | |
| 09-Apr-24 6:38 PM View: | Gustafson Kurt A Executive VP, Finance and CFO | Omniab, Inc. (OABI) | 07-Apr-24 | Option Exercise | 13,541 | -- | -- | 8% 170.11K to 183.65K | |
| 09-Apr-24 6:37 PM View: | Berkman Charles S Chief Legal Officer | Omniab, Inc. (OABI) | 07-Apr-24 | Option Exercise | 13,541 | -- | -- | 5% 286.03K to 299.57K | |
| 09-Apr-24 6:38 PM View: | Foehr Matthew W President and CEO Director | Omniab, Inc. (OABI) | 07-Apr-24 | Option Exercise | 36,458 | -- | -- | 1% 3.15M to 3.19M | |
| 02-Apr-24 6:30 PM View: | Gustafson Kurt A Executive VP, Finance & CFO | Omniab, Inc. (OABI) | 01-Apr-24 | Option Exercise | 23,254 | -- | -- | 15% 158.71K to 181.96K | |
| 02-Apr-24 6:30 PM View: | Gustafson Kurt A Executive VP, Finance & CFO | Omniab, Inc. (OABI) | 01-Apr-24 | Option Sale | 11,849 | $5.46 | $64,695.50 | (7%) 181.96K to 170.11K | |
| 29-Mar-24 4:52 PM View: | Foehr Matthew W President and CEO Director | Omniab, Inc. (OABI) | 27-Mar-24 | Option Exercise | 243,613 | $3.72 | $907,023.00 | 8% 2.91M to 3.15M | |
| 25-Mar-24 7:07 AM View: | Foehr Matthew W President and CEO Director | Omniab, Inc. (OABI) | 22-Mar-24 | Purchase | 225,000 | $5.19 | $1,167,750.00 | 8% 2.68M to 2.91M | |
| 20-Feb-24 6:22 PM View: | Berkman Charles S Chief Legal Officer | Omniab, Inc. (OABI) | 15-Feb-24 | Option Exercise | 21,322 | -- | -- | 8% 272.32K to 293.64K | |
| 20-Feb-24 6:22 PM View: | Foehr Matthew W Chief Executive Officer Director | Omniab, Inc. (OABI) | 15-Feb-24 | Payment of Exercise | 18,919 | $5.54 | $104,811.00 | (< 1%) 2.7M to 2.68M | |
| 20-Feb-24 6:22 PM View: | Foehr Matthew W Chief Executive Officer Director | Omniab, Inc. (OABI) | 15-Feb-24 | Option Exercise | 37,328 | -- | -- | 1% 2.67M to 2.7M | |
| 20-Feb-24 6:22 PM View: | Berkman Charles S Chief Legal Officer | Omniab, Inc. (OABI) | 15-Feb-24 | Payment of Exercise | 7,609 | $5.54 | $42,153.90 | (3%) 293.64K to 286.03K | |
| 31-Jan-24 7:58 PM View: | Higgins John L Director | Omniab, Inc. (OABI) | 30-Jan-24 | Option Exercise | 13,173 | -- | -- | < 1% 2.34M to 2.35M | |
| 03-Jan-24 5:42 PM View: | Berkman Charles S Chief Legal Officer | Omniab, Inc. (OABI) | 02-Jan-24 | Option Exercise | 17,556 | -- | -- | 7% 261.96K to 279.51K | |
| 03-Jan-24 5:42 PM View: | Foehr Matthew W Chief Executive Officer Director | Omniab, Inc. (OABI) | 02-Jan-24 | Option Exercise | 33,173 | -- | -- | 1% 2.65M to 2.68M | |
| 03-Jan-24 5:42 PM View: | Berkman Charles S Chief Legal Officer | Omniab, Inc. (OABI) | 02-Jan-24 | Payment of Exercise | 7,195 | $6.25 | $44,968.80 | (3%) 279.51K to 272.32K | |
| 03-Jan-24 5:42 PM View: | Foehr Matthew W Chief Executive Officer Director | Omniab, Inc. (OABI) | 02-Jan-24 | Payment of Exercise | 13,221 | $6.25 | $82,631.20 | (< 1%) 2.68M to 2.67M | |
| 13-Dec-23 3:25 PM View: | Foehr Matthew W Chief Executive Officer Director | Omniab, Inc. (OABI) | 12-Dec-23 | Purchase | 200,000 | $5.05 | $1,010,000.00 | 8% 2.45M to 2.65M | |
| 11-Dec-23 7:21 PM View: | Berkman Charles S Chief Legal Officer | Omniab, Inc. (OABI) | 07-Dec-23 | Option Exercise | 15,622 | -- | -- | 6% 251.74K to 267.36K | |
| 11-Dec-23 7:24 PM View: | Foehr Matthew W Chief Executive Officer Director | Omniab, Inc. (OABI) | 07-Dec-23 | Option Exercise | 26,556 | -- | -- | 1% 2.43M to 2.45M | |
| 11-Dec-23 7:21 PM View: | Berkman Charles S Chief Legal Officer | Omniab, Inc. (OABI) | 07-Dec-23 | Payment of Exercise | 5,403 | $4.85 | $26,204.50 | (2%) 267.36K to 261.96K | |
| 11-Dec-23 7:51 PM View: | Gustafson Kurt A Executive VP, Finance & CFO | Omniab, Inc. (OABI) | 07-Dec-23 | Payment of Exercise | 16,081 | $4.85 | $77,992.90 | (9%) 174.79K to 158.71K | |
| 11-Dec-23 7:24 PM View: | Foehr Matthew W Chief Executive Officer Director | Omniab, Inc. (OABI) | 07-Dec-23 | Payment of Exercise | 9,184 | $4.85 | $44,542.40 | (< 1%) 2.45M to 2.45M | |
| 11-Dec-23 7:51 PM View: | Gustafson Kurt A Executive VP, Finance & CFO | Omniab, Inc. (OABI) | 07-Dec-23 | Option Exercise | 46,503 | -- | -- | 36% 128.28K to 174.79K | |
| 13-Nov-23 8:00 AM View: | Foehr Matthew W President and CEO Director | Omniab, Inc. (OABI) | 10-Nov-23 | Purchase | 95,000 | $4.27 | $405,517.00 | 4% 2.33M to 2.43M | |
| 14-Nov-23 9:47 PM View: | Avista Capital Managing Mem... Director 10% Owner | Omniab, Inc. (OABI) | 01-Nov-23 | Option Exercise Duplicate | 17,770 | -- | -- | < 1% 15.82M to 15.84M | |
| 01-Nov-23 5:51 PM View: | Bertozzi Carolyn R Director | Omniab, Inc. (OABI) | 01-Nov-23 | Option Exercise | 17,770 | -- | -- | 100% 0 to 17.77K | |
| 15-Aug-23 4:56 PM View: | Foehr Matthew W President and CEO Director | Omniab, Inc. (OABI) | 14-Aug-23 | Purchase | 45,000 | $5.48 | $246,600.00 | 2% 2.29M to 2.33M | |
| 14-Jul-23 4:19 PM View: | Cochran Jennifer R. Director | Omniab, Inc. (OABI) | 12-Jul-23 | Option Exercise | 1,896 | -- | -- | 2% 91.19K to 93.09K | |
| 12-Jun-23 4:47 PM View: | Foehr Matthew W Chief Executive Officer Director | Omniab, Inc. (OABI) | 09-Jun-23 | Purchase | 115,000 | $4.52 | $519,800.00 | 5% 2.46M to 2.57M | |
| 25-May-23 4:45 PM View: | Higgins John L Director | Omniab, Inc. (OABI) | 23-May-23 | Option Exercise | 9,000 | $3.68 | $33,120.00 | < 1% 2.46M to 2.47M | |
| 25-May-23 4:45 PM View: | Higgins John L Director | Omniab, Inc. (OABI) | 23-May-23 | Option Sale | 9,000 | $4.05 | $36,450.00 | (< 1%) 2.47M to 2.46M | |
| 23-May-23 4:12 PM View: | Higgins John L Director | Omniab, Inc. (OABI) | 19-May-23 | Option Exercise | 1,000 | $3.68 | $3,680.00 | < 1% 2.46M to 2.46M | |
| 23-May-23 4:12 PM View: | Higgins John L Director | Omniab, Inc. (OABI) | 19-May-23 | Option Sale | 1,000 | $4.05 | $4,050.00 | (< 1%) 2.46M to 2.46M | |
| 19-May-23 5:03 PM View: | Higgins John L Director | Omniab, Inc. (OABI) | 18-May-23 | Option Exercise | 50,000 | $3.68 | $184,000.00 | 2% 2.46M to 2.51M | |
| 19-May-23 5:03 PM View: | Higgins John L Director | Omniab, Inc. (OABI) | 18-May-23 | Option Sale | 50,000 | $3.89 | $194,500.00 | (2%) 2.51M to 2.46M | |
| 15-May-23 4:02 PM View: | Foehr Matthew W Chief Executive Officer Director | Omniab, Inc. (OABI) | 12-May-23 | Purchase | 440,000 | $3.40 | $1,496,000.00 | 22% 2.0M to 2.44M | |
| 11-Apr-23 7:11 PM View: | Foehr Matthew W Chief Executive Officer Director | Omniab, Inc. (OABI) | 07-Apr-23 | Grant | 109,375 | -- | -- | 6% 1.89M to 2.0M | |
| 11-Apr-23 7:11 PM View: | Gustafson Kurt A Executive VP, Finance & CFO | Omniab, Inc. (OABI) | 07-Apr-23 | Grant | 40,625 | -- | -- | 14% 294.79K to 335.42K | |
| 11-Apr-23 7:11 PM View: | Berkman Charles S Chief Legal Officer | Omniab, Inc. (OABI) | 07-Apr-23 | Grant | 40,625 | -- | -- | 11% 373.94K to 414.56K | |
| 04-Apr-23 4:57 PM View: | Gustafson Kurt A EVP, Finance and CFO | Omniab, Inc. (OABI) | 01-Apr-23 | Payment of Exercise | 8,042 | $3.68 | $29,594.60 | (3%) 302.83K to 294.79K | |
| 17-Feb-23 7:50 PM View: | Berkman Charles S Chief Legal Officer | Omniab, Inc. (OABI) | 15-Feb-23 | Payment of Exercise | 9,543 | $3.80 | $36,263.40 | (2%) 383.48K to 373.94K | |
| 17-Feb-23 7:28 PM View: | Foehr Matthew W President and CEO Director | Omniab, Inc. (OABI) | 15-Feb-23 | Payment of Exercise | 17,086 | $3.80 | $64,926.80 | (< 1%) 1.91M to 1.89M | |
| 01-Feb-23 2:28 PM View: | Cochran Jennifer R. Director | Omniab, Inc. (OABI) | 30-Jan-23 | Grant | 17,506 | -- | -- | 23% 77.48K to 94.98K | |
| 01-Feb-23 2:29 PM View: | Patel Sunil Director | Omniab, Inc. (OABI) | 30-Jan-23 | Grant | 8,753 | -- | -- | 4% 215.51K to 224.26K | |
| 01-Feb-23 2:29 PM View: | Higgins John L Director | Omniab, Inc. (OABI) | 30-Jan-23 | Grant | 39,517 | -- | -- | 2% 2.42M to 2.46M | |
| 01-Feb-23 2:10 PM View: | Boyce Sarah Director | Omniab, Inc. (OABI) | 30-Jan-23 | Grant | 8,753 | -- | -- | 12% 73.44K to 82.19K | |
| 27-Jun-23 6:33 PM View: | Higgins John L Director | Omniab, Inc. (OABI) | 04-Jan-23 | Payment of Exercise | 57,803 | $3.23 | $186,704.00 | 3% 2.28M to 2.34M |
